Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05165056 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity

Study acronym: GynLight
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2022 to Aug 24, 2022
    • Site details revised at 2 of 2 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to investigate the effectiveness of photobiomodulation therapy (PBMT) in the prevention and management of radiotherapy-induced vaginal toxicity (RIVT). Therefore, we hypothesize that PBMT can reduce the severity of RIVT in gynecological cancer patients, increasing the patient's QoL and sexual functioning.
Trial Details
NCT Number NCT05165056
Lead Sponsor Jessa Hospital
Collaborators: Ziekenhuis Oost-Limburg, Hasselt University
Conditions
(from sponsor)		 Radiotherapy Side Effect, Vaginal Abnormality
Related terms Radiation Injuries
Enrollment 62 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov